Treatment of the cells with arginine-glycine-aspartic acid (RGD) peptides that block the interactions between integrins, in particular α5β1, and their ligands (Hynes, 2002), almost completely prevented the adhesion of ASM-treated tumor cells to fibronectin-coated cover slips (Fig5D). The gene discussed is FN1; the disease is neoplasm.